Jantoven
Links shared publicly online about this topic
Jantoven 3mg tablets recalled due to mislabeling - ONA
oncologynurseadvisor.com — “Upsher-Smith Laboratories announced a nationwide voluntary recall of Jantoven (warfarin sodium) 3mg tablets with an expiration date of September 2012, NDC # 0832-1214-00.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 17, 2011 at 3:30 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Jantoven 3mg tablets recalled due to mislabeling http://goo.gl/fb/bEtvj
Consumer Reports Health Blog: Jantoven warfarin tablets recalled nationwide
blogs.consumerreports.org — “Health Blog: News, research, and expert perspectives on wellness, prescriptin drugs, conditions and treaments, health care, and natural medicine that help you make better health choices for you and your family.” View full resource at blogs.consumerreports.org
Most Recently Shared on February 26, 2011 at 8:35 pm By:
Thomas Loarie, Jr Health Advocate
Consumer Reports - Jantoven warfarin tablets recalled nationwide http://bit.ly/fiDIgb
FDA Alert: Warfarin Sodium Tablets (Jantoven), 3mg: Recall - Mislabeled Bottles Containing Higher Dosage
drugs.com — “FDA Alert: Warfarin Sodium Tablets (Jantoven), 3mg: Recall - Mislabeled Bottles Containing Higher Dosage” View full resource at drugs.com
Most Recently Shared on February 17, 2011 at 11:17 pm By:
FDA Alert - Recall: Warfarin Sodium Tablets (Jantoven) 3mg - Mislabeled Bottles Containing Higher Dosage - http://bit.ly/haTsTS
Upsher-Smith Labs Recalls Jantoven Warfarin Sodium Tablets Due To Mislabeled Bottles
usrecallnews.com — “Upsher-Smith Laboratories Inc. is recalling one lot (lot #284081) of Jantoven® Warfarin Sodium, USP, 3mg Tablets, an anticoagulant with an expiration date of September 2012. The company is initiating the recall as a precautionary measure after a single bottle labeled as Jantoven® Warfarin Sodium, USP, 3mg Tablets was found to contain tablets at a higher, 10mg strength before it was dispensed.” View full resource at usrecallnews.com
Most Recently Shared on February 18, 2011 at 3:14 pm By:
Upsher-Smith Labs Recalls Jantoven Warfarin Sodium Tablets Due To Mislabeled Bottles http://f.ast.ly/VBJPc
Upsher-Smith Laboratories Announces Expansion of Voluntary Nationwide Recall. Affected Products Include Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantoven® and Oxybutynin
fda.gov — “Upsher-Smith Laboratories, Inc., of Maple Grove, Minnesota is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010. The company is initiating the recall as a precautionary measure after a bottle labeled as Jantoven® Warfarin Sodium, USP, 3 mg Tablets was found by a retail pharmacy to contain tablets at a higher, 10 mg str” View full resource at fda.gov
Most Recently Shared on February 19, 2011 at 6:22 pm By:
Ohio Family Practice Physician Group
Drug recall expanded to include: Amantadine, Amlodipine, Baclofen, Bethanechol, Jantoven® and Oxybutynin http://goo.gl/5hQnK
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on February 18, 2011 at 2:36 pm By:
One lot of warfarin recalled: Upsher-Smith is recalling lot #284081 of its Jantoven 3 mg after discovering one b... http://bit.ly/gBKK9k
New Atrial Fibrillation Drug Pradaxa Approved
webmd.com — “The FDA has approved Pradaxa, a new drug to prevent blood clots in patients with atrial fibrillation.” View full resource at webmd.com
Most Recently Shared on October 20, 2010 at 6:51 pm By:
New Atrial Fibrillation Drug Pradaxa Approved: The FDA has approved Pradaxa, a new drug to prevent blood clots in ... http://bit.ly/9pqyyn
Warfarin sodium tablets recalled | HemOncToday
hemonctoday.com — “One lot of Jantoven Warfarin Sodium, USP, 3 mg tablets with an expiration date of September 2012 was recalled as a precautionary measure afte” View full resource at hemonctoday.com
Most Recently Shared on February 17, 2011 at 9:22 pm By:
HemOnc Today Oncology and Health News
#Warfarin sodium tablets recalled http://bit.ly/fXkqe8
Upsher-Smith Labs Announces Expansion of Nationwide Recall on Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, Jantovena and Oxybutynin
usrecallnews.com — “Upsher-Smith Laboratories, Inc., is voluntarily expanding its previously announced recall of Jantoven® Warfarin Sodium, USP, 3 mg Tablets. The tablets were found by a retail pharmacy to contain tablets at a higher, 10 mg strength.” View full resource at usrecallnews.com
Most Recently Shared on February 21, 2011 at 3:09 pm By:
Upsher-Smith Labs Announces Expansion of Nationwide Recall on Amantadine, Amlodipine, Androxy, Baclofen, Bethanechol, http://f.ast.ly/qebTD
Upsher-Smith expands nationwide product recall - MPR
empr.com — “Upsher-Smith Laboratories is voluntarily expanding its previously announced recall of Jantoven (warfarin sodium) 3mg tablets to include additional products that were packaged on the same packaging line between May 17, 2010 and November 17, 2010.” View full resource at empr.com
Most Recently Shared on February 22, 2011 at 7:03 pm By:
MPR News: Upsher-Smith expands nationwide product recall: Upsher-Smith Laboratories is voluntarily expanding its... http://bit.ly/dNGUPs
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
OncologyNurseAdvisor
Oncology Nurse Advisor offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
-
Thomas Loarie, Jr
Medical Health Information you can use! I'm committed to finding positive, useful, educational and hopefully inspirational medical health news!
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
